Company Presentation • 12 Nov 2024 22:30
Company Presentation • 14 Dec 2022 04:00
Company Presentation • 07 Aug 2024 19:00
Company Presentation • 08 May 2024 19:00
Company Presentation • 09 Nov 2023 19:00
ENTITY
BeiGene (6160 HK)
BeiGene (6160 HK)
327
Analysis
Health Care • China
BeiGene, Ltd. operates as a commercial stage biopharmaceutical company. The Company focuses on discovery, development, and commercialization of molecularly targeted and immuno-oncology drugs for the treatment of cancer. BeiGene serves patients worldwide.
more
x